Zota Health Care Ltd. · NSE:ZOTA
Zota Health Care — Q3 FY21 Earnings Presentation
24 slides from Zota Health Care's earnings presentation, Feb 13, 2021
Slide 1: Cover letter to NSE for investor presentation
A zoto' healthcare ltd. February 13,2021. To, The Manager Listing Department, The National Stock Exchange of tndia Limited Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai - 400051 Dear Sir/Madam, Trading Symbol: ZOTA Sub: lnvestor Presentation Ref: Regulation 30 of SEBI (Listing obtigations
Slide 2: Q3FY21 Performance Highlights
Q4&FY20 Q3FY21 PPerformance E R F O R M A N C E HHighlights IGHLIGHTS February J U N E 2 0 2 2021 0
Slide 3: Safe Harbor
Safe Harbor This presentation has been prepared by the Zota Health Care Limited (the “Company”) only for information purpose to the stakeholders and does not contain any offer or invitation to subscribe the securities of the Company. No offering of securities shall be made except by means of offer d
Slide 4: Table Of Contents
Table Of Contents 1 Result Highlights 2 Operational Metrics 3 Davaindia 4 Business Outlook & Strategy 5 Financial Summary 3
Slide 5: Qtr- Result Highlights
A Zoid Qtr- Result Highlights
Slide 6: Consol Quarterly Financial Highlights
Consol Quarterly Financial Highlights Q-o-Q 3048.27 85.24 2816.64 33.56% 101.71 29.78% Q3-FY21 Q2-FY21 Q3-FY21 Q2-FY21 -100.79 -118.70 Q3-FY21 Q2-FY21 Q3-FY21 Q2-FY21 Revenues (Rs Lakhs) Gross Profit (%) Operating Profit (Rs Lakhs) PAT (Rs Lakhs) Y-o-Y 38.01 73.32 3048.27 29.78% 28.73% 2506.38 Q3-FY
Slide 7: Revenue Break up – Quarterly
Revenue Break up – Quarterly Domestic Sales Davaindia Sales 1556.58 1516.60 693.50 574.97 1334.52 351.00 Q3-FY21 Q2-FY21 Q3-FY20 Q3-FY21 Q2-FY21 Q3-FY20 Export Sales (SEZ) 1020.25 685.09 638.80 Q3-FY21 Q2-FY21 Q3-FY20 6
Slide 8: FY- Result Highlights
A Zoid FY- Result Highlights
Slide 9: Consol Profit & Loss Statement - Quarterly
Consol Profit & Loss Statement - Quarterly Particulars (Rs Lakhs) Q3FY21 Q3FY20 YoY % QoQ % Q2FY21 Export Sales (SEZ) 1,020.25 638.8 60% 49% 685.09 Dava India Sales 693.5 351 98% 21% 574.97 Domestic Sales 1,334.52 1,516.60 -12% -14% 1,556.58 Revenues from Operations 3,048.27 2,506.38 22% 8% 2,816.64
Slide 10: Management Commentary
Management Commentary • The new-age businesses of the Company i.e. Davaindia and Exports have recorded their best ever quarterly performance in terms of Revenue from Operations in Q3FY21. • This is in line with the Company’s strategy of increasing overall Revenue contribution from new-age businesses
Slide 11: Management Commentary: Domestic Operations and Exports
Management Commentary Domestic Operations • Revenue from Domestic operations has been surged by 8.59% Y-o-Y basis, on account of higher revenue of Davaindia. The company has registered the domestic revenues of 2028.02 Lakhs in Q3FY21. • With increasing revenue of Davaindia; the management is well po
Slide 12: Davaindia Generic Pharmacy
healthcare Itd. GY davaindia’ GENERIC PHARMACY
Slide 13: Davaindia Key Figures
Davaindia Key Figures SKU’s 1353 1368 1371 1333 1338 1310 1250 1100 1150 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Q2-FY21 Q3-FY21 Stores rolled-out 109 99 45 39 33 29 29 32 31 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Q2-FY21 Q3-FY21 12
Slide 14: Davaindia Key Figures
Davaindia Key Figures Average Wallet Spend No. of Customers Served 209 355731 338415 352623 181 159 164 275520 152 267030 259022 132 136 231100 221975 126 116 83925 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Q2-FY21 Q3-FY21 Q3-FY19 Q4-FY19 Q1-FY20 Q2-FY20 Q3-FY20 Q4-FY20 Q1-FY21 Q2-FY21
Slide 15: Davaindia caters to 3.56 lakh customers in the quarter
• During the quarter Davaindia has catered to 3.56 lakhs customers, increasing Average Wallet Spends has led to Revenue growth of 21% from Davaindia on Q-o-Q basis. The same is up 98% on Y-o-Y basis, driven by increasing customers served and Average Wallet Spends. • Davaindia has led the revolution
Slide 16: 15
15
Slide 17: Davaindia Footprints
Davaindia Footprints KASHMIR (2) HIMACHAL PRADESH (3) PUNJAB (8) HARYANA (22) NEW DELHI (34) Yamunanagar, Kurukshetra, Bhiwani, Hisar,Faridabad, UTTARAKHAND (4) Yamunanagar, Panipat Dehradun, Araghar RAJASTHAN (18) ) Jodhpur, Sikar, Shri AASAM (4) Jaipur, Ganganagar, Nagpur, UTTAR PRADESH (60) Bhara
Slide 18: Industry Snapshot & Business Strategy
Industry Snapshot & Business Strategy
Slide 19: India's Retail Generic Medicine Landscape
India‘s Retail Generic Medicine Landscape Jan Aushadhi Stores -A key initiative against t he high priced selling Our Honourable Prime Minister launched ‘Jan Aushadhi medicines in the market Kendras’ under the ‘Pradhan Mantri Bhartiya Janaushahi Pariyojana’ (PMBJP) scheme. Jan Aushadhi Stores rolled-
Slide 20: Underpenetrated Generic Medicine Market
Underpenetrated Generic Medicine Market 4 pillars to drive healthcare Branded and generic mix of Indian pharma market 19
Slide 21: Financial Summary
ml ae Financial Summary A Zoid
Slide 22: Profit & Loss Statement
Profit & Loss Statement Particulars (INR Lakhs) FY15 FY16 FY17 FY18 FY19 FY20 Q3FY21 Income from Operations 5,646.3 6,473.3 7,158.0 7,785.2 8,562.9 9,511.3 3048.27 Other Income 1.4 7.7 5.6 151.9 154.5 151.3 57.15 Total Income 5,647.8 6,481.0 7,163.6 7,937.0 8,717.4 9,662.6 3105.42 Operating Expenses
Slide 23: Balance Sheet & Key Ratios
Balance Sheet & Key Ratios Particulars (INR Lakhs) FY14 FY15 FY16 FY17 FY18 FY19 FY20 H1FY21 Share capital 1,196.9 1,436.3 1,436.3 1,436.3 1,754.3 1,754.3 2,456.0 2,456.0 Reserves and Surplus 384.2 395.7 707.8 1,262.0 5,223.4 5,138.2 4,426.9 4,590.0 Non-current liabilities 521.3 548.7 272.7 466.8 64
Slide 24: Thank You
Contact Information Mr. Himanshu Zota / Mr. Ashvin Variya "ZOTA HOUSE", 2/896, Hira Modi Street, Sagrampura, Surat-395 002(Gujarat) cszota@zotahealthcare.com www.zotahealthcare.com Thank You